Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. LabCorp Indiana Inc.
EIR
•LabCorp Indiana Inc.•July 13, 2021

LabCorp Indiana Inc. – FDA EIR, Jul 13, 2021

Record Details

An FDA priority inspection of LabCorp Indiana Inc., located in South Bend, IN, was conducted from July 7 to July 13, 2021. This comprehensive surveillance inspection, guided by CPGM 7341.002 for Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps), found the firm operating as a contract testing laboratory for a hematopoietic stem cell manufacturer. The inspection focused on the firm's quality program, standard operating procedures, training, equipment maintenance, and sterility testing deviations. A significant observation, documented on an FDA Form 483, highlighted that the firm's quality program failed to investigate, document, or report deviations related to sterility testing protocols, specifically three instances of analyzer malfunctions in February and October 2020, and June 2021. These malfunctions affected numerous HCT/P sterility tests and were not properly addressed in accordance with 21 CFR 1271.160(b)(6). Additionally, the inspection revealed a lack of consistent quality oversight, with the quality program not performing reviews for over five months, nor leading quality meetings since February 2021. There was also a failure to track and trend deviations for approximately a year, with no Quality Management Reports generated since the second quarter of 2020. Management indicated that LabCorp Indiana Inc. or its parent company would likely respond to the FDA's observations within the 15-day timeframe and stated intentions to review and improve their practices.

Company
LabCorp Indiana Inc.
Inspection date
July 13, 2021
Product type
biologics
Office
Chicago District Office
People
  • Matthew J. Gretkierewicz (issuing_officer)
  • Jennifer A. Kemp (issuing_officer)
View Company Profile

ID · 550c71ad-89f8-49bf-93b0-1933b66b11d3

Violation Codes1
21 CFR 1271.160(b)(6)

Full citation text and observation details available on the Dashboard.

Other documents for LabCorp Indiana Inc.
  • 483 - 2021-07-13July 13, 2021

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore LabCorp Indiana Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.